Medtronic MDT 4.69%increase; green up pointing triangle raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.
The medical-device maker said Tuesday it now expects organic revenue to grow about 5.5% from its last fiscal year, compared with a prior outlook of up 5%. The company also raised the low end of its adjusted earnings outlook to $5.62 a share from $5.60 a share, while maintaining the high end at $5.66 a share.
Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
